Apart from its angiogenic and vascular permeation activity, the vascular endothelial growth factor (VEGF) has been also reported as a potent neuronal protector. Newborn rats with low VEGF levels develop neuron degeneration, while high levels induce protective mechanisms in several neuropathological conditions. Phoneutria nigriventer spider venom (PNV) disrupts the blood-brain barrier (BBB) and causes neuroinflammation in central neurons along with excitotoxic signals in rats and humans. All these changes are transient. Herein, we examined the expression of VEGF and its receptors, Flt-1 and Flk-1 in the hippocampal neurons following envenomation by PNV. Adult and neonatal rats were evaluated at time limits of 2, 5 and 24 h. Additionally, BBB integrity was assessed by measuring the expression of occludin, β-catenin and laminin and neuron viability was evaluated by NeuN expression. VEGF, Flt-1 and Flk-1 levels increased in PNV-administered rats, concurrently with respective mRNAs. Flt-1 and Flk-1 immunolabeling was nuclear in neurons of hippocampal regions, instead of the VEGF membrane-bound typical location. These changes occurred simultaneously with the transient decreases in BBB-associated proteins and NeuN positivity. Adult rats showed more prominent expressional increases of the VEGF/Flt-1/Flk-1 system and earlier recovery of BBB-related proteins than neonates. We conclude that the reactive expressional changes seen here suggest that VEGF and receptors could have a role in the excitotoxic mechanism of PNV and that such role would be less efficient in neonate rats.
References
[1]
Vassilevsky, A.A.; Koslov, S.A.; Egorov, T.A.; Grishin, E.V. Purification and characterization of biologically active peptides from spider venoms. Methods Mol. Biol. 2010, 615, 87–100, doi:10.1007/978-1-60761-535-4_7.
[2]
Reis, H.J.; Prado, M.A.; Kalapothakis, E.; Cordeiro, M.N.; Diniz, C.R.; de Marco, L.A.; Gomez, M.V.; Romano-Silva, M.A. Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin 3–4) from the spider Phoneutria nigriventer. Biochem. J. 1999, 343, 413–418, doi:10.1042/0264-6021:3430413.
[3]
Gomez, M.V.; Kalapothakis, E.; Guatimosim, C.; Prado, M.A. Phoneutria nigriventer venom: A cocktail of toxins that affect ion channels. Cell. Mol. Neurobiol. 2002, 22, 579–588, doi:10.1023/A:1021836403433.
[4]
Bucaretchi, F.; Deus Reinaldo, C.R.; Hyslop, S.; Madureira, P.R.; de Capitani, E.M.; Vieira, R.J. A clinico-epidemiological study of bites by spiders of the genus Phoneutria. Rev. Inst. Med. Trop. S？o Paulo 2000, 42, 17–21.
[5]
Le Sueur, L.; Kalapothakis, E.; Cruz-H？fling, M.A. Breakdown of the blood-brain barrier and neuropathological changes induced by Phoneutria nigriventer spider venom. Acta Neuropathol. 2003, 105, 125–134.
[6]
Le Sueur, L.; Collares-Buzato, C.B.; Cruz-H？fling, M.A. Mechanisms involved in the blood-brain barrier increased permeability induced by Phoneutria nigriventer spider venom in rats. Brain Res. 2004, 1027, 38–47, doi:10.1016/j.brainres.2004.08.055.
[7]
Rap？so, C.; Odorissi, P.A.M.; Oliveira, A.L.R.; Aoyama, H.; Ferreira, C.V.; Verinaud, L.; Fontana, K.; Ruela-de-Sousa, R.R.; da Cruz-H？fling, M.A. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem. Res. 2012, 37, 1967–1981, doi:10.1007/s11064-012-0817-y.
Olsson, A.K.; Dimberg, A.; Kreuger, J.; Claesson-Welsh, L. VEGF receptor signaling in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7, 359–371, doi:10.1038/nrm1911.
[10]
Sk？ld, M.K.; Risling, M.; Holmin, S. Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. Eur. J. Neurosci. 2006, 23, 21–34, doi:10.1111/j.1460-9568.2005.04527.x.
[11]
Ruiz de Almodovar, C.; Lambrechts, D.; Mazzone, M.; Carmeliet, P. Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 2009, 89, 607–648, doi:10.1152/physrev.00031.2008.
[12]
Morin-Brureau, M.; Rigau, V.; Lerner-Natoli, M. Why and how to target angiogenesis in focal epilepsies. Epilepsia 2012, 53, 64–68, doi:10.1111/j.1528-1167.2012.03705.x.
[13]
Rap？so, C.; Zago, G.M.; Silva, G.H.; Cruz-H？fling, M.A. Acute blood brain barrier permeabilization in rats after systemic Phoneutria nigriventer venom. Brain Res. 2007, 1149, 18–29, doi:10.1016/j.brainres.2007.02.086.
[14]
Mendon？a, M.C.; Soares, E.S.; Stávale, L.M.; Irazusta, S.P.; Cruz-H？fling, M.A. Upregulation of the vascular endothelial growth factor, Flt-1, in rat hippocampal neurons after envenoming by Phoneutria nigriventer; age-related modulation. Toxicon 2012, 60, 656–664, doi:10.1016/j.toxicon.2012.05.015.
[15]
Cruz-H？fling, M.A.; Zago, G.M.; Melo, L.L.; Rap？so, C. C-FOS and n-NOS reactive neurons in response to circulating Phoneutria nigriventer spider venom. Brain Res. Bull. 2007, 73, 114–126, doi:10.1016/j.brainresbull.2007.01.017.
[16]
Cruz-H？fling, M.A.; Rap？so, C.; Verinaud, L.; Zago, G.M. Neuroinflammationand astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening. Neurotoxicology 2009, 30, 636–646, doi:10.1016/j.neuro.2009.04.004.
[17]
Jin, K.; Zhu, Y.; Sun, Y.; Mao, X.O.; Xie, L.; Greenberg, D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2002, 99, 11946–11950, doi:10.1073/pnas.182296499.
[18]
Ferrara, N.; Gerber, H.P.; le Couter, J. The biology of VEGF and its receptors. Nat. Med. 2003, 9, 669–676, doi:10.1038/nm0603-669.
[19]
Semenza, G. Signal transductions to hypoxia-inducible factor 1. Biochem. Pharmacol. 2002, 64, 993–998.
[20]
Góra-Kupilas, K.; Jo？ko, J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005, 43, 31–39.
[21]
Zachary, I. Neuroprotective role of vascular endothelial growth factor: Signaling mechanisms, biological function, and therapeutic potential. Neurosignals 2005, 14, 207–221, doi:10.1159/000088637.
[22]
Ogunshola, O.O.; Al-Ahmad, A. HIF-1 at the blood-brain barrier: A mediator of permeability? High Alt. Med. Biol. 2012, 13, 153–161, doi:10.1089/ham.2012.1052.
[23]
Stávale, L.M.; Soares, E.S.; Mendon？a, M.C.; Irazusta, S.P.; da Cruz H？fling, M.A. Temporal relationship between aquaporin-4 and glial fibrillary acidic protein in cerebellum of neonate and adult rats administered a BBB disrupting spider venom. Toxicon 2013, 66, 37–46, doi:10.1016/j.toxicon.2013.01.026.
[24]
Risau, W.; Esser, S.; Engelhardt, B. Differentiation of blood-brain barrier endothelial cells. Pathol. Biol. 1998, 46, 171–175.
[25]
Witt, K.A.; Mark, K.S.; Hom, S.; Davis, T.P. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2820–H2831.
[26]
Nico, B.; Ribatti, D. Morphofunctional aspects of the blood-brain barrier. Curr. Drug Metab. 2012, 13, 50–60, doi:10.2174/138920012798356970.
[27]
Zachary, I.; Gliki, G. Signaling transduction mechanism mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 2001, 49, 568–581, doi:10.1016/S0008-6363(00)00268-6.
[28]
Neuwelt, E.; Abbott, N.J.; Abrey, L.; Banks, W.A.; Blakley, B.; Davis, T.; Engelhardt, B.; Grammas, P.; Nedergaard, M.; Nutt, J.; et al. Strategies to advance translational research into brain barriers. Lancet Neurol. 2008, 7, 84–96, doi:10.1016/S1474-4422(07)70326-5.
[29]
Zlokovic, B.V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 2011, 12, 723–738.
[30]
Tillo, M.; Ruhrberg, C.; Mackenzie, F. Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity. Cell Adhes. Migr. 2012, 6, 541–546, doi:10.4161/cam.22408.
[31]
Dent, M.A.; Segura-Araya, E.; Alva-Medina, J.; Aranda-Anzaldo, A. NeuN/Fox-3 is an intrinsic component of the neuronal nuclear matrix. FEBS Lett. 2010, 584, 2767–2771, doi:10.1016/j.febslet.2010.04.073.
[32]
Snyder, J.S.; Ferrante, S.C.; Cameron, H.A. Late maturation of adult-born neurons in the temporal dentate gyrus. PLoS One 2012, 7, e48757.
[33]
Amaral, D.G.; Scharfman, H.E.; Lavenex, P. The dentate gyrus: Fundamental neuroanatomical organization (dentate gyrus for dummies). Prog. Brain Res. 2007, 163, 3–22, doi:10.1016/S0079-6123(07)63001-5.
[34]
Treves, A.; Tashiro, A.; Witter, M.E.; Moser, E.I. What is the mammalian dentate gyrus good for? Neuroscience 2008, 154, 1155–1172, doi:10.1016/j.neuroscience.2008.04.073.
[35]
Prado, M.A.; Guatimosim, C.; Gomez, M.V.; Diniz, C.; Cordeiro, M.N.; Romano-Silva, M.A. A novel tool for the investigation of glutamate release from rat cerebrocorticalsynaptosomes: The toxin Tx3–3 from the venom of the spider Phoneutria nigriventer. Biochem. J. 1996, 314(Pt 1), 145–150.
[36]
Vieira, L.B.; Kushmerick, C.; Reis, H.J.; Diniz, C.R.; Cordeiro, M.N.; Prado, M.A.; Kalapothakis, E.; Romano-Silva, M.A.; Gomez, M.V. PnTx3–6 a spider neurotoxin inhibits K+-evoked increase in Ca2+(i) and Ca2+-dependent glutamate release in synaptosomes. Neurochem. Int. 2003, 42, 277–282, doi:10.1016/S0197-0186(02)00130-4.
[37]
Mafra, R.A.; Figueiredo, S.G.; Diniz, C.R.; Cordeiro, M.N.; Cruz, J.D.; de Lima, M.E. PhTx4, a new class of toxins from Phoneutria nigriventer spider venom inhibits the glutamate uptake in rat brain synaptosomes. Brain Res. 1999, 831, 297–300, doi:10.1016/S0006-8993(99)01472-9.
[38]
Meissirel, C.; Ruiz de Almodovar, C.; Knevels, E.; Coulon, C.; Chounlamountri, N.; Segura, I.; de Rossi, P.; Vinckier, S.; Anthonis, K.; Deléglise, B.; et al. VEGF modulates NMDA receptors activity in cerebellar granule cells trough Src-family kinases before synapse formation. Proc. Natl. Acad. Sci. USA 2011, 108, 13782–13787, doi:10.1073/pnas.1100341108.
[39]
Ma, Y.Y.; Li, K.Y.; Huang, Y.L.; Huang, Y.; Sun, F.Y. Vascular endothelial growth factor acutely reduces calcium influx via inhibition of the Ca2+ channels in rat hippocampal neurons. J. Neurosci. Res. 2009, 87, 393–402, doi:10.1002/jnr.21859.
[40]
Bogaert, E.; van Damme, P.; Poesen, K.; Dhondt, J.; Hersmus, N.; Kiraly, D.; Scheveneels, W.; Robberecht, W.; van den Bosch, L. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiology 2010, 31, 2185–2191.
[41]
Cammalleri, M.; Martini, D.; Ristori, C.; Timperio, A.M.; Bagnoli, P. Vascular endothelial growth factor up-regulation in the mouse hippocampus and its role in the control of epileptiform activity. Eur. J. Neurosci. 2011, 33, 482–498, doi:10.1111/j.1460-9568.2010.07529.x.
[42]
Mukherjee, S.; Tessema, M.; Wandinger-Ness, A. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Circ. Res. 2006, 98, 743–756, doi:10.1161/01.RES.0000214545.99387.e3.
[43]
Orth, J.D.; McNiven, M.A. Get off my back! Rapid receptor internalization through circular dorsal ruffles. Cancer Res. 2006, 66, 11094–11096, doi:10.1158/0008-5472.CAN-06-3397.
